CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
IGEA Pharma NV Company Snapshot
IGEA Pharma NV operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares IGEA Pharma NV with three other pharmaceutical manufacturers in Europe: Index Pharmaceuticals Holding Ab of Sweden (2017 sales of 113,000.00 Swedish Kronor [US$11,654.82 ] ), Oncoarendi Therapeutics SA of Poland (6,000.00 Polish New Zlotys [US$1,549.20 ] ), and Irlab Therapeutics Ab which is based in Sweden (109,000.00 Swedish Kronor [US$11,242.26 ] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for IGEA Pharma NV
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): .80
(Figures in Euro)
1 Week -10.3%   13 Weeks -25.8%  
4 Weeks -43.6%   52 Weeks n/a  
 
IGEA Pharma NV Key Data:
  Ticker: IGPH Country: Netherlands
  Exchanges: AMS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 6,845
(Year Ending Jan 2018).
Employees: N/A
  Currency: Euro Market Cap: 20,105,895
  Fiscal Yr Ends: December Shares Outstanding: 25,048,769
  Share Type: Ordinary Closely Held Shares: 16,558,292
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.